Free tool
FAERS Monitor: Proscar
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020180 or its brand name (Proscar, Finasteride). Reports on generic versions are filed under their own applications.
Reports
56,555
Serious
36,655
65% of reports
Hospitalization
15,545
Death reported
5,077
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue3,717
- adverse drug reaction2,724
- erectile dysfunction2,620
- depression2,600
- drug ineffective2,431
- diarrhoea2,356
- dizziness2,345
- death2,299
- anxiety2,145
- dyspnoea2,104
- asthenia2,064
- off label use1,981
- insomnia1,840
- fall1,810
- nausea1,578
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 474 |
| 2005 | 527 |
| 2006 | 556 |
| 2007 | 448 |
| 2008 | 520 |
| 2009 | 570 |
| 2010 | 827 |
| 2011 | 1,088 |
| 2012 | 1,319 |
| 2013 | 1,506 |
| 2014 | 1,783 |
| 2015 | 2,803 |
| 2016 | 3,186 |
| 2017 | 3,165 |
| 2018 | 3,770 |
| 2019 | 3,560 |
| 2020 | 4,032 |
| 2021 | 3,416 |
| 2022 | 3,184 |
| 2023 | 3,041 |
| 2024 | 5,048 |
| 2025 | 7,296 |
| 2026 | 4,435 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,997,604 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| erectile dysfunctionSignal | 2,620 | 42.1 | 40.5 | 94,588 |
| adverse drug reactionSignal | 2,724 | 11.6 | 11.2 | 25,685 |
| depressionSignal | 2,600 | 4.3 | 4.1 | 6,546 |
| anxietySignal | 2,145 | 2.8 | 2.7 | 2,527 |
| insomniaSignal | 1,840 | 2.6 | 2.5 | 1,789 |
| astheniaSignal | 2,064 | 2.0 | 2.0 | 1,119 |
| fallSignal | 1,810 | 2.0 | 1.9 | 952 |
| fatigue | 3,717 | 1.8 | 1.7 | 1,310 |
| dizziness | 2,345 | 1.8 | 1.7 | 771 |
| dyspnoea | 2,104 | 1.4 | 1.3 | 229 |
| diarrhoea | 2,356 | 1.4 | 1.3 | 229 |
| death | 2,299 | 1.0 | 1.0 | 0 |
| off label use | 1,981 | 0.8 | 0.8 | 62 |
| nausea | 1,578 | 0.7 | 0.7 | 148 |
| drug ineffective | 2,431 | 0.7 | 0.7 | 373 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.